Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches

Activating Liver X receptors (LXRs) represents a promising therapeutic option for dyslipidemia. However, activating LXRα may cause undesired lipogenic effects. Discovery of highly LXRβ-selective agonists without LXRα activation were indispensable for dyslipidemia. In this study, in...

Full description

Bibliographic Details

Main Authors:	Meimei Chen, Fafu Yang, Jie Kang, Huijuan Gan, Xuemei Yang, Xinmei Lai, Yuxing Gao
Format:	Artigo
Language:	Inglês
Published:	MDPI AG 2018-06-01
Series:	Molecules
Subjects:	LXRβ-selective agonists QSAR modeling molecular docking Kohonen
Online Access:	http://www.mdpi.com/1420-3049/23/6/1349
Tags:	Add Tag No Tags, Be the first to tag this record!